Drug Type CAR-T |
Synonyms- |
Target |
Mechanism BCMA modulators(B-cell maturation protein modulators), SLAMF7 modulators(SLAM family member 7 modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
NCT04662099 (ASH2022) Manual | Phase 1 | 16 | hktwommrft(wzzkftpevy) = not observed axpfdagzuf (djjehzpydl ) | Positive | 15 Nov 2022 | ||
NCT04662099 (EHA2022) Manual | Phase 1 | 13 | chemotherapy+CS1-BCMA CAR-T cells | ggneyqzmbj(hhvvgpuuyf) = jbxdrxovhr uhfzhjsove (hyfgvyozqo ) View more | Positive | 12 May 2022 |